INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4001, 28282, 'Carbamazepine', 'Alcohol may potentiate some of the pharmacologic effects of carbamazepine.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving carbamazepine should be advised to avoid or limit consumption of alcohol.  Given the drug''s narrow therapeutic index, patients receiving carbamazepine therapy should preferably avoid the regular consumption of grapefruits and grapefruit juice to prevent any undue fluctuations in plasma drug levels.  Patients should be advised to report signs of carbamazepine toxicity (nausea, visual disturbances, dizziness, or ataxia) to their physicians.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4002, 16030, 'Cefpodoxime', 'Food enhances the oral bioavailability of cefpodoxime proxetil tablets.', 'food', 'Moderate', 'To ensure maximal oral absorption, cefpodoxime proxetil tablets should be administered with or immediately after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4003, 16031, 'Cefpodoxime', 'Food enhances the oral bioavailability of cefpodoxime proxetil tablets.', 'food', 'Moderate', 'To ensure maximal oral absorption, cefpodoxime proxetil tablets should be administered with or immediately after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4004, 16032, 'Cefpodoxime', 'Food enhances the oral bioavailability of cefpodoxime proxetil tablets.', 'food', 'Moderate', 'To ensure maximal oral absorption, cefpodoxime proxetil tablets should be administered with or immediately after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4005, 16055, 'Cefpodoxime', 'Food enhances the oral bioavailability of cefpodoxime proxetil tablets.', 'food', 'Moderate', 'To ensure maximal oral absorption, cefpodoxime proxetil tablets should be administered with or immediately after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4006, 16135, 'Cefpodoxime', 'Food enhances the oral bioavailability of cefpodoxime proxetil tablets.', 'food', 'Moderate', 'To ensure maximal oral absorption, cefpodoxime proxetil tablets should be administered with or immediately after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4007, 17873, 'Cefpodoxime', 'Food enhances the oral bioavailability of cefpodoxime proxetil tablets.', 'food', 'Moderate', 'To ensure maximal oral absorption, cefpodoxime proxetil tablets should be administered with or immediately after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4008, 22405, 'Cefpodoxime', 'Food enhances the oral bioavailability of cefpodoxime proxetil tablets.', 'food', 'Moderate', 'To ensure maximal oral absorption, cefpodoxime proxetil tablets should be administered with or immediately after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4009, 24243, 'Cefpodoxime', 'Food enhances the oral bioavailability of cefpodoxime proxetil tablets.', 'food', 'Moderate', 'To ensure maximal oral absorption, cefpodoxime proxetil tablets should be administered with or immediately after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4010, 24244, 'Cefpodoxime', 'Food enhances the oral bioavailability of cefpodoxime proxetil tablets.', 'food', 'Moderate', 'To ensure maximal oral absorption, cefpodoxime proxetil tablets should be administered with or immediately after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4011, 25018, 'Cefpodoxime', 'Food enhances the oral bioavailability of cefpodoxime proxetil tablets.', 'food', 'Moderate', 'To ensure maximal oral absorption, cefpodoxime proxetil tablets should be administered with or immediately after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4012, 25019, 'Cefpodoxime', 'Food enhances the oral bioavailability of cefpodoxime proxetil tablets.', 'food', 'Moderate', 'To ensure maximal oral absorption, cefpodoxime proxetil tablets should be administered with or immediately after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4013, 25020, 'Cefpodoxime', 'Food enhances the oral bioavailability of cefpodoxime proxetil tablets.', 'food', 'Moderate', 'To ensure maximal oral absorption, cefpodoxime proxetil tablets should be administered with or immediately after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4014, 25021, 'Cefpodoxime', 'Food enhances the oral bioavailability of cefpodoxime proxetil tablets.', 'food', 'Moderate', 'To ensure maximal oral absorption, cefpodoxime proxetil tablets should be administered with or immediately after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4015, 27381, 'Cefpodoxime', 'Food enhances the oral bioavailability of cefpodoxime proxetil tablets.', 'food', 'Moderate', 'To ensure maximal oral absorption, cefpodoxime proxetil tablets should be administered with or immediately after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4016, 28143, 'Cefpodoxime', 'Food enhances the oral bioavailability of cefpodoxime proxetil tablets.', 'food', 'Moderate', 'To ensure maximal oral absorption, cefpodoxime proxetil tablets should be administered with or immediately after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4017, 16063, 'Ceftibuten', 'Food reduces the oral absorption and bioavailability of ceftibuten.  According to the product labeling, administration of ceftibuten oral suspension with a high-fat breakfast decreased the mean peak plasma concentration (Cmax) and area under the concentration-time curve (AUC) by 26% and 17%, respectively.', 'high-fat foods', 'Moderate', 'To ensure maximal oral absorption, ceftibuten oral suspension should be taken at least two hours before or one hour after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4018, 26912, 'Ceftibuten', 'Food reduces the oral absorption and bioavailability of ceftibuten.  According to the product labeling, administration of ceftibuten oral suspension with a high-fat breakfast decreased the mean peak plasma concentration (Cmax) and area under the concentration-time curve (AUC) by 26% and 17%, respectively.', 'high-fat foods', 'Moderate', 'To ensure maximal oral absorption, ceftibuten oral suspension should be taken at least two hours before or one hour after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4019, 26913, 'Ceftibuten', 'Food reduces the oral absorption and bioavailability of ceftibuten.  According to the product labeling, administration of ceftibuten oral suspension with a high-fat breakfast decreased the mean peak plasma concentration (Cmax) and area under the concentration-time curve (AUC) by 26% and 17%, respectively.', 'high-fat foods', 'Moderate', 'To ensure maximal oral absorption, ceftibuten oral suspension should be taken at least two hours before or one hour after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4020, 2224, 'Cefoperazone', 'Some cephalosporins may occasionally induce a disulfiram-like reaction when coadministered with alcohol.  The interaction has been reported for cefamandole, cefoperazone, cefotetan, and moxalactam.  These agents contain an N-methylthiotetrazole (NMTT) side chain that may inhibit aldehyde dehydrogenase (ALDH) similar to disulfiram.  Following ingestion of alcohol, inhibition of ALDH results in increased concentration of acetaldehyde, the accumulation of which produces an unpleasant physiologic response referred to as the ''disulfiram reaction''.  Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion.  Severe reactions may result in respiratory depression, cardiovascular collapse, arrh', 'alcohol', 'Moderate', 'Patients receiving cephalosporins with the NMTT side chain should avoid the concomitant use of alcohol and alcohol-containing products.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4021, 2270, 'Cefoperazone', 'Some cephalosporins may occasionally induce a disulfiram-like reaction when coadministered with alcohol.  The interaction has been reported for cefamandole, cefoperazone, cefotetan, and moxalactam.  These agents contain an N-methylthiotetrazole (NMTT) side chain that may inhibit aldehyde dehydrogenase (ALDH) similar to disulfiram.  Following ingestion of alcohol, inhibition of ALDH results in increased concentration of acetaldehyde, the accumulation of which produces an unpleasant physiologic response referred to as the ''disulfiram reaction''.  Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion.  Severe reactions may result in respiratory depression, cardiovascular collapse, arrh', 'alcohol', 'Moderate', 'Patients receiving cephalosporins with the NMTT side chain should avoid the concomitant use of alcohol and alcohol-containing products.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4022, 2274, 'Cefoperazone', 'Some cephalosporins may occasionally induce a disulfiram-like reaction when coadministered with alcohol.  The interaction has been reported for cefamandole, cefoperazone, cefotetan, and moxalactam.  These agents contain an N-methylthiotetrazole (NMTT) side chain that may inhibit aldehyde dehydrogenase (ALDH) similar to disulfiram.  Following ingestion of alcohol, inhibition of ALDH results in increased concentration of acetaldehyde, the accumulation of which produces an unpleasant physiologic response referred to as the ''disulfiram reaction''.  Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion.  Severe reactions may result in respiratory depression, cardiovascular collapse, arrh', 'alcohol', 'Moderate', 'Patients receiving cephalosporins with the NMTT side chain should avoid the concomitant use of alcohol and alcohol-containing products.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4023, 2278, 'Cefoperazone', 'Some cephalosporins may occasionally induce a disulfiram-like reaction when coadministered with alcohol.  The interaction has been reported for cefamandole, cefoperazone, cefotetan, and moxalactam.  These agents contain an N-methylthiotetrazole (NMTT) side chain that may inhibit aldehyde dehydrogenase (ALDH) similar to disulfiram.  Following ingestion of alcohol, inhibition of ALDH results in increased concentration of acetaldehyde, the accumulation of which produces an unpleasant physiologic response referred to as the ''disulfiram reaction''.  Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion.  Severe reactions may result in respiratory depression, cardiovascular collapse, arrh', 'alcohol', 'Moderate', 'Patients receiving cephalosporins with the NMTT side chain should avoid the concomitant use of alcohol and alcohol-containing products.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4024, 2279, 'Cefoperazone', 'Some cephalosporins may occasionally induce a disulfiram-like reaction when coadministered with alcohol.  The interaction has been reported for cefamandole, cefoperazone, cefotetan, and moxalactam.  These agents contain an N-methylthiotetrazole (NMTT) side chain that may inhibit aldehyde dehydrogenase (ALDH) similar to disulfiram.  Following ingestion of alcohol, inhibition of ALDH results in increased concentration of acetaldehyde, the accumulation of which produces an unpleasant physiologic response referred to as the ''disulfiram reaction''.  Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion.  Severe reactions may result in respiratory depression, cardiovascular collapse, arrh', 'alcohol', 'Moderate', 'Patients receiving cephalosporins with the NMTT side chain should avoid the concomitant use of alcohol and alcohol-containing products.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4025, 6385, 'Cefoperazone', 'Some cephalosporins may occasionally induce a disulfiram-like reaction when coadministered with alcohol.  The interaction has been reported for cefamandole, cefoperazone, cefotetan, and moxalactam.  These agents contain an N-methylthiotetrazole (NMTT) side chain that may inhibit aldehyde dehydrogenase (ALDH) similar to disulfiram.  Following ingestion of alcohol, inhibition of ALDH results in increased concentration of acetaldehyde, the accumulation of which produces an unpleasant physiologic response referred to as the ''disulfiram reaction''.  Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion.  Severe reactions may result in respiratory depression, cardiovascular collapse, arrh', 'alcohol', 'Moderate', 'Patients receiving cephalosporins with the NMTT side chain should avoid the concomitant use of alcohol and alcohol-containing products.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4026, 16001, 'Cefoperazone', 'Some cephalosporins may occasionally induce a disulfiram-like reaction when coadministered with alcohol.  The interaction has been reported for cefamandole, cefoperazone, cefotetan, and moxalactam.  These agents contain an N-methylthiotetrazole (NMTT) side chain that may inhibit aldehyde dehydrogenase (ALDH) similar to disulfiram.  Following ingestion of alcohol, inhibition of ALDH results in increased concentration of acetaldehyde, the accumulation of which produces an unpleasant physiologic response referred to as the ''disulfiram reaction''.  Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion.  Severe reactions may result in respiratory depression, cardiovascular collapse, arrh', 'alcohol', 'Moderate', 'Patients receiving cephalosporins with the NMTT side chain should avoid the concomitant use of alcohol and alcohol-containing products.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4027, 16002, 'Cefoperazone', 'Some cephalosporins may occasionally induce a disulfiram-like reaction when coadministered with alcohol.  The interaction has been reported for cefamandole, cefoperazone, cefotetan, and moxalactam.  These agents contain an N-methylthiotetrazole (NMTT) side chain that may inhibit aldehyde dehydrogenase (ALDH) similar to disulfiram.  Following ingestion of alcohol, inhibition of ALDH results in increased concentration of acetaldehyde, the accumulation of which produces an unpleasant physiologic response referred to as the ''disulfiram reaction''.  Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion.  Severe reactions may result in respiratory depression, cardiovascular collapse, arrh', 'alcohol', 'Moderate', 'Patients receiving cephalosporins with the NMTT side chain should avoid the concomitant use of alcohol and alcohol-containing products.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4028, 16022, 'Cefoperazone', 'Some cephalosporins may occasionally induce a disulfiram-like reaction when coadministered with alcohol.  The interaction has been reported for cefamandole, cefoperazone, cefotetan, and moxalactam.  These agents contain an N-methylthiotetrazole (NMTT) side chain that may inhibit aldehyde dehydrogenase (ALDH) similar to disulfiram.  Following ingestion of alcohol, inhibition of ALDH results in increased concentration of acetaldehyde, the accumulation of which produces an unpleasant physiologic response referred to as the ''disulfiram reaction''.  Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion.  Severe reactions may result in respiratory depression, cardiovascular collapse, arrh', 'alcohol', 'Moderate', 'Patients receiving cephalosporins with the NMTT side chain should avoid the concomitant use of alcohol and alcohol-containing products.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4029, 16023, 'Cefoperazone', 'Some cephalosporins may occasionally induce a disulfiram-like reaction when coadministered with alcohol.  The interaction has been reported for cefamandole, cefoperazone, cefotetan, and moxalactam.  These agents contain an N-methylthiotetrazole (NMTT) side chain that may inhibit aldehyde dehydrogenase (ALDH) similar to disulfiram.  Following ingestion of alcohol, inhibition of ALDH results in increased concentration of acetaldehyde, the accumulation of which produces an unpleasant physiologic response referred to as the ''disulfiram reaction''.  Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion.  Severe reactions may result in respiratory depression, cardiovascular collapse, arrh', 'alcohol', 'Moderate', 'Patients receiving cephalosporins with the NMTT side chain should avoid the concomitant use of alcohol and alcohol-containing products.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4030, 16024, 'Cefoperazone', 'Some cephalosporins may occasionally induce a disulfiram-like reaction when coadministered with alcohol.  The interaction has been reported for cefamandole, cefoperazone, cefotetan, and moxalactam.  These agents contain an N-methylthiotetrazole (NMTT) side chain that may inhibit aldehyde dehydrogenase (ALDH) similar to disulfiram.  Following ingestion of alcohol, inhibition of ALDH results in increased concentration of acetaldehyde, the accumulation of which produces an unpleasant physiologic response referred to as the ''disulfiram reaction''.  Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion.  Severe reactions may result in respiratory depression, cardiovascular collapse, arrh', 'alcohol', 'Moderate', 'Patients receiving cephalosporins with the NMTT side chain should avoid the concomitant use of alcohol and alcohol-containing products.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4031, 16028, 'Cefoperazone', 'Some cephalosporins may occasionally induce a disulfiram-like reaction when coadministered with alcohol.  The interaction has been reported for cefamandole, cefoperazone, cefotetan, and moxalactam.  These agents contain an N-methylthiotetrazole (NMTT) side chain that may inhibit aldehyde dehydrogenase (ALDH) similar to disulfiram.  Following ingestion of alcohol, inhibition of ALDH results in increased concentration of acetaldehyde, the accumulation of which produces an unpleasant physiologic response referred to as the ''disulfiram reaction''.  Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion.  Severe reactions may result in respiratory depression, cardiovascular collapse, arrh', 'alcohol', 'Moderate', 'Patients receiving cephalosporins with the NMTT side chain should avoid the concomitant use of alcohol and alcohol-containing products.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4032, 16051, 'Cefoperazone', 'Some cephalosporins may occasionally induce a disulfiram-like reaction when coadministered with alcohol.  The interaction has been reported for cefamandole, cefoperazone, cefotetan, and moxalactam.  These agents contain an N-methylthiotetrazole (NMTT) side chain that may inhibit aldehyde dehydrogenase (ALDH) similar to disulfiram.  Following ingestion of alcohol, inhibition of ALDH results in increased concentration of acetaldehyde, the accumulation of which produces an unpleasant physiologic response referred to as the ''disulfiram reaction''.  Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion.  Severe reactions may result in respiratory depression, cardiovascular collapse, arrh', 'alcohol', 'Moderate', 'Patients receiving cephalosporins with the NMTT side chain should avoid the concomitant use of alcohol and alcohol-containing products.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4033, 16052, 'Cefoperazone', 'Some cephalosporins may occasionally induce a disulfiram-like reaction when coadministered with alcohol.  The interaction has been reported for cefamandole, cefoperazone, cefotetan, and moxalactam.  These agents contain an N-methylthiotetrazole (NMTT) side chain that may inhibit aldehyde dehydrogenase (ALDH) similar to disulfiram.  Following ingestion of alcohol, inhibition of ALDH results in increased concentration of acetaldehyde, the accumulation of which produces an unpleasant physiologic response referred to as the ''disulfiram reaction''.  Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion.  Severe reactions may result in respiratory depression, cardiovascular collapse, arrh', 'alcohol', 'Moderate', 'Patients receiving cephalosporins with the NMTT side chain should avoid the concomitant use of alcohol and alcohol-containing products.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4034, 16057, 'Cefoperazone', 'Some cephalosporins may occasionally induce a disulfiram-like reaction when coadministered with alcohol.  The interaction has been reported for cefamandole, cefoperazone, cefotetan, and moxalactam.  These agents contain an N-methylthiotetrazole (NMTT) side chain that may inhibit aldehyde dehydrogenase (ALDH) similar to disulfiram.  Following ingestion of alcohol, inhibition of ALDH results in increased concentration of acetaldehyde, the accumulation of which produces an unpleasant physiologic response referred to as the ''disulfiram reaction''.  Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion.  Severe reactions may result in respiratory depression, cardiovascular collapse, arrh', 'alcohol', 'Moderate', 'Patients receiving cephalosporins with the NMTT side chain should avoid the concomitant use of alcohol and alcohol-containing products.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4035, 16060, 'Cefoperazone', 'Some cephalosporins may occasionally induce a disulfiram-like reaction when coadministered with alcohol.  The interaction has been reported for cefamandole, cefoperazone, cefotetan, and moxalactam.  These agents contain an N-methylthiotetrazole (NMTT) side chain that may inhibit aldehyde dehydrogenase (ALDH) similar to disulfiram.  Following ingestion of alcohol, inhibition of ALDH results in increased concentration of acetaldehyde, the accumulation of which produces an unpleasant physiologic response referred to as the ''disulfiram reaction''.  Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion.  Severe reactions may result in respiratory depression, cardiovascular collapse, arrh', 'alcohol', 'Moderate', 'Patients receiving cephalosporins with the NMTT side chain should avoid the concomitant use of alcohol and alcohol-containing products.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4036, 16296, 'Cefoperazone', 'Some cephalosporins may occasionally induce a disulfiram-like reaction when coadministered with alcohol.  The interaction has been reported for cefamandole, cefoperazone, cefotetan, and moxalactam.  These agents contain an N-methylthiotetrazole (NMTT) side chain that may inhibit aldehyde dehydrogenase (ALDH) similar to disulfiram.  Following ingestion of alcohol, inhibition of ALDH results in increased concentration of acetaldehyde, the accumulation of which produces an unpleasant physiologic response referred to as the ''disulfiram reaction''.  Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion.  Severe reactions may result in respiratory depression, cardiovascular collapse, arrh', 'alcohol', 'Moderate', 'Patients receiving cephalosporins with the NMTT side chain should avoid the concomitant use of alcohol and alcohol-containing products.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4037, 22387, 'Cefoperazone', 'Some cephalosporins may occasionally induce a disulfiram-like reaction when coadministered with alcohol.  The interaction has been reported for cefamandole, cefoperazone, cefotetan, and moxalactam.  These agents contain an N-methylthiotetrazole (NMTT) side chain that may inhibit aldehyde dehydrogenase (ALDH) similar to disulfiram.  Following ingestion of alcohol, inhibition of ALDH results in increased concentration of acetaldehyde, the accumulation of which produces an unpleasant physiologic response referred to as the ''disulfiram reaction''.  Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion.  Severe reactions may result in respiratory depression, cardiovascular collapse, arrh', 'alcohol', 'Moderate', 'Patients receiving cephalosporins with the NMTT side chain should avoid the concomitant use of alcohol and alcohol-containing products.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4038, 24726, 'Cefoperazone', 'Some cephalosporins may occasionally induce a disulfiram-like reaction when coadministered with alcohol.  The interaction has been reported for cefamandole, cefoperazone, cefotetan, and moxalactam.  These agents contain an N-methylthiotetrazole (NMTT) side chain that may inhibit aldehyde dehydrogenase (ALDH) similar to disulfiram.  Following ingestion of alcohol, inhibition of ALDH results in increased concentration of acetaldehyde, the accumulation of which produces an unpleasant physiologic response referred to as the ''disulfiram reaction''.  Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion.  Severe reactions may result in respiratory depression, cardiovascular collapse, arrh', 'alcohol', 'Moderate', 'Patients receiving cephalosporins with the NMTT side chain should avoid the concomitant use of alcohol and alcohol-containing products.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4039, 24727, 'Cefoperazone', 'Some cephalosporins may occasionally induce a disulfiram-like reaction when coadministered with alcohol.  The interaction has been reported for cefamandole, cefoperazone, cefotetan, and moxalactam.  These agents contain an N-methylthiotetrazole (NMTT) side chain that may inhibit aldehyde dehydrogenase (ALDH) similar to disulfiram.  Following ingestion of alcohol, inhibition of ALDH results in increased concentration of acetaldehyde, the accumulation of which produces an unpleasant physiologic response referred to as the ''disulfiram reaction''.  Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion.  Severe reactions may result in respiratory depression, cardiovascular collapse, arrh', 'alcohol', 'Moderate', 'Patients receiving cephalosporins with the NMTT side chain should avoid the concomitant use of alcohol and alcohol-containing products.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4040, 0, 'Cefotetan', 'Some cephalosporins may occasionally induce a disulfiram-like reaction when coadministered with alcohol.  The interaction has been reported for cefamandole, cefoperazone, cefotetan, and moxalactam.  These agents contain an N-methylthiotetrazole (NMTT) side chain that may inhibit aldehyde dehydrogenase (ALDH) similar to disulfiram.  Following ingestion of alcohol, inhibition of ALDH results in increased concentration of acetaldehyde, the accumulation of which produces an unpleasant physiologic response referred to as the ''disulfiram reaction''.  Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion.  Severe reactions may result in respiratory depression, cardiovascular collapse, arrhythmias, myocardial infarction, acute congestive heart failure, unconsciousness, convulsions, and death.', 'alcohol', 'Moderate', 'Patients receiving cephalosporins with the NMTT side chain should avoid the concomitant use of alcohol and alcohol-containing products.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4041, 0, 'Cenobamate', 'Alcohol may potentiate some of the pharmacologic effects of central nervous system (CNS)-active agents.  Use in combination may result in additive CNS depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled against driving, operating machinery, or engaging in potentially hazardous activities requiring mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4042, 289, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4043, 290, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4044, 2447, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4045, 2448, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4046, 2449, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4047, 2450, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4048, 4296, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4049, 4297, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4050, 5611, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4051, 6178, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4052, 6179, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4053, 6180, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4054, 6589, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4055, 11497, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4056, 12961, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4057, 12962, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4058, 13672, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4059, 16201, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4060, 16203, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4061, 16204, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4062, 19023, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4063, 20507, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4064, 20520, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4065, 21714, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4066, 28269, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4067, 30065, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4068, 32143, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4069, 32489, 'Cetirizine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4070, 0, 'Ceritinib', 'Grapefruit juice may increase the plasma concentrations of ceritinib.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', 'Patients treated with ceritinib should avoid consumption of grapefruit, grapefruit juice, and any supplement containing grapefruit extract.  Ceritinib should be administered on an empty stomach (i.e., avoid administration within 2 hours of a meal).', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4071, 468, 'Albendazole', 'Food enhances the oral bioavailability of albendazole, which is rapidly converted by hepatocytes and intestinal mucosal cells into the active metabolite, albendazole sulfoxide (ABZSX), following absorption.  The proposed mechanism is stimulation of gastric acid secretion, as the absorption of albendazole is thought to be pH-dependent.  According to the product labeling, plasma concentrations of ABZSX are up to 5-fold higher on average when albendazole is administered with a fatty meal (fat content approximately 40 g) compared to administration in the fasted state.', 'high-fat foods', 'Moderate', 'To ensure maximal oral absorption, albendazole should be taken with food.  Grapefruit juice may also enhance the oral bioavailability of albendazole.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4072, 470, 'Albendazole', 'Food enhances the oral bioavailability of albendazole, which is rapidly converted by hepatocytes and intestinal mucosal cells into the active metabolite, albendazole sulfoxide (ABZSX), following absorption.  The proposed mechanism is stimulation of gastric acid secretion, as the absorption of albendazole is thought to be pH-dependent.  According to the product labeling, plasma concentrations of ABZSX are up to 5-fold higher on average when albendazole is administered with a fatty meal (fat content approximately 40 g) compared to administration in the fasted state.', 'high-fat foods', 'Moderate', 'To ensure maximal oral absorption, albendazole should be taken with food.  Grapefruit juice may also enhance the oral bioavailability of albendazole.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4073, 807, 'Albendazole', 'Food enhances the oral bioavailability of albendazole, which is rapidly converted by hepatocytes and intestinal mucosal cells into the active metabolite, albendazole sulfoxide (ABZSX), following absorption.  The proposed mechanism is stimulation of gastric acid secretion, as the absorption of albendazole is thought to be pH-dependent.  According to the product labeling, plasma concentrations of ABZSX are up to 5-fold higher on average when albendazole is administered with a fatty meal (fat content approximately 40 g) compared to administration in the fasted state.', 'high-fat foods', 'Moderate', 'To ensure maximal oral absorption, albendazole should be taken with food.  Grapefruit juice may also enhance the oral bioavailability of albendazole.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4074, 809, 'Albendazole', 'Food enhances the oral bioavailability of albendazole, which is rapidly converted by hepatocytes and intestinal mucosal cells into the active metabolite, albendazole sulfoxide (ABZSX), following absorption.  The proposed mechanism is stimulation of gastric acid secretion, as the absorption of albendazole is thought to be pH-dependent.  According to the product labeling, plasma concentrations of ABZSX are up to 5-fold higher on average when albendazole is administered with a fatty meal (fat content approximately 40 g) compared to administration in the fasted state.', 'high-fat foods', 'Moderate', 'To ensure maximal oral absorption, albendazole should be taken with food.  Grapefruit juice may also enhance the oral bioavailability of albendazole.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4075, 1381, 'Albendazole', 'Food enhances the oral bioavailability of albendazole, which is rapidly converted by hepatocytes and intestinal mucosal cells into the active metabolite, albendazole sulfoxide (ABZSX), following absorption.  The proposed mechanism is stimulation of gastric acid secretion, as the absorption of albendazole is thought to be pH-dependent.  According to the product labeling, plasma concentrations of ABZSX are up to 5-fold higher on average when albendazole is administered with a fatty meal (fat content approximately 40 g) compared to administration in the fasted state.', 'high-fat foods', 'Moderate', 'To ensure maximal oral absorption, albendazole should be taken with food.  Grapefruit juice may also enhance the oral bioavailability of albendazole.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4076, 12234, 'Albendazole', 'Food enhances the oral bioavailability of albendazole, which is rapidly converted by hepatocytes and intestinal mucosal cells into the active metabolite, albendazole sulfoxide (ABZSX), following absorption.  The proposed mechanism is stimulation of gastric acid secretion, as the absorption of albendazole is thought to be pH-dependent.  According to the product labeling, plasma concentrations of ABZSX are up to 5-fold higher on average when albendazole is administered with a fatty meal (fat content approximately 40 g) compared to administration in the fasted state.', 'high-fat foods', 'Moderate', 'To ensure maximal oral absorption, albendazole should be taken with food.  Grapefruit juice may also enhance the oral bioavailability of albendazole.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4077, 12236, 'Albendazole', 'Food enhances the oral bioavailability of albendazole, which is rapidly converted by hepatocytes and intestinal mucosal cells into the active metabolite, albendazole sulfoxide (ABZSX), following absorption.  The proposed mechanism is stimulation of gastric acid secretion, as the absorption of albendazole is thought to be pH-dependent.  According to the product labeling, plasma concentrations of ABZSX are up to 5-fold higher on average when albendazole is administered with a fatty meal (fat content approximately 40 g) compared to administration in the fasted state.', 'high-fat foods', 'Moderate', 'To ensure maximal oral absorption, albendazole should be taken with food.  Grapefruit juice may also enhance the oral bioavailability of albendazole.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4078, 13623, 'Albendazole', 'Food enhances the oral bioavailability of albendazole, which is rapidly converted by hepatocytes and intestinal mucosal cells into the active metabolite, albendazole sulfoxide (ABZSX), following absorption.  The proposed mechanism is stimulation of gastric acid secretion, as the absorption of albendazole is thought to be pH-dependent.  According to the product labeling, plasma concentrations of ABZSX are up to 5-fold higher on average when albendazole is administered with a fatty meal (fat content approximately 40 g) compared to administration in the fasted state.', 'high-fat foods', 'Moderate', 'To ensure maximal oral absorption, albendazole should be taken with food.  Grapefruit juice may also enhance the oral bioavailability of albendazole.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4079, 13624, 'Albendazole', 'Food enhances the oral bioavailability of albendazole, which is rapidly converted by hepatocytes and intestinal mucosal cells into the active metabolite, albendazole sulfoxide (ABZSX), following absorption.  The proposed mechanism is stimulation of gastric acid secretion, as the absorption of albendazole is thought to be pH-dependent.  According to the product labeling, plasma concentrations of ABZSX are up to 5-fold higher on average when albendazole is administered with a fatty meal (fat content approximately 40 g) compared to administration in the fasted state.', 'high-fat foods', 'Moderate', 'To ensure maximal oral absorption, albendazole should be taken with food.  Grapefruit juice may also enhance the oral bioavailability of albendazole.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4080, 13872, 'Albendazole', 'Food enhances the oral bioavailability of albendazole, which is rapidly converted by hepatocytes and intestinal mucosal cells into the active metabolite, albendazole sulfoxide (ABZSX), following absorption.  The proposed mechanism is stimulation of gastric acid secretion, as the absorption of albendazole is thought to be pH-dependent.  According to the product labeling, plasma concentrations of ABZSX are up to 5-fold higher on average when albendazole is administered with a fatty meal (fat content approximately 40 g) compared to administration in the fasted state.', 'high-fat foods', 'Moderate', 'To ensure maximal oral absorption, albendazole should be taken with food.  Grapefruit juice may also enhance the oral bioavailability of albendazole.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4081, 15064, 'Albendazole', 'Food enhances the oral bioavailability of albendazole, which is rapidly converted by hepatocytes and intestinal mucosal cells into the active metabolite, albendazole sulfoxide (ABZSX), following absorption.  The proposed mechanism is stimulation of gastric acid secretion, as the absorption of albendazole is thought to be pH-dependent.  According to the product labeling, plasma concentrations of ABZSX are up to 5-fold higher on average when albendazole is administered with a fatty meal (fat content approximately 40 g) compared to administration in the fasted state.', 'high-fat foods', 'Moderate', 'To ensure maximal oral absorption, albendazole should be taken with food.  Grapefruit juice may also enhance the oral bioavailability of albendazole.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4082, 468, 'Albendazole', 'Food enhances the oral bioavailability of albendazole, which is rapidly converted by hepatocytes and intestinal mucosal cells into the active metabolite, albendazole sulfoxide (ABZSX), following absorption.  The proposed mechanism is stimulation of gastric acid secretion, as the absorption of albendazole is thought to be pH-dependent.  According to the product labeling, plasma concentrations of ABZSX are up to 5-fold higher on average when albendazole is administered with a fatty meal (fat content approximately 40 g) compared to administration in the fasted state.', 'grapefruit juice', 'Moderate', 'To ensure maximal oral absorption, albendazole should be taken with food.  Grapefruit juice may also enhance the oral bioavailability of albendazole.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4083, 470, 'Albendazole', 'Food enhances the oral bioavailability of albendazole, which is rapidly converted by hepatocytes and intestinal mucosal cells into the active metabolite, albendazole sulfoxide (ABZSX), following absorption.  The proposed mechanism is stimulation of gastric acid secretion, as the absorption of albendazole is thought to be pH-dependent.  According to the product labeling, plasma concentrations of ABZSX are up to 5-fold higher on average when albendazole is administered with a fatty meal (fat content approximately 40 g) compared to administration in the fasted state.', 'grapefruit juice', 'Moderate', 'To ensure maximal oral absorption, albendazole should be taken with food.  Grapefruit juice may also enhance the oral bioavailability of albendazole.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4084, 807, 'Albendazole', 'Food enhances the oral bioavailability of albendazole, which is rapidly converted by hepatocytes and intestinal mucosal cells into the active metabolite, albendazole sulfoxide (ABZSX), following absorption.  The proposed mechanism is stimulation of gastric acid secretion, as the absorption of albendazole is thought to be pH-dependent.  According to the product labeling, plasma concentrations of ABZSX are up to 5-fold higher on average when albendazole is administered with a fatty meal (fat content approximately 40 g) compared to administration in the fasted state.', 'grapefruit juice', 'Moderate', 'To ensure maximal oral absorption, albendazole should be taken with food.  Grapefruit juice may also enhance the oral bioavailability of albendazole.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4085, 809, 'Albendazole', 'Food enhances the oral bioavailability of albendazole, which is rapidly converted by hepatocytes and intestinal mucosal cells into the active metabolite, albendazole sulfoxide (ABZSX), following absorption.  The proposed mechanism is stimulation of gastric acid secretion, as the absorption of albendazole is thought to be pH-dependent.  According to the product labeling, plasma concentrations of ABZSX are up to 5-fold higher on average when albendazole is administered with a fatty meal (fat content approximately 40 g) compared to administration in the fasted state.', 'grapefruit juice', 'Moderate', 'To ensure maximal oral absorption, albendazole should be taken with food.  Grapefruit juice may also enhance the oral bioavailability of albendazole.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4086, 1381, 'Albendazole', 'Food enhances the oral bioavailability of albendazole, which is rapidly converted by hepatocytes and intestinal mucosal cells into the active metabolite, albendazole sulfoxide (ABZSX), following absorption.  The proposed mechanism is stimulation of gastric acid secretion, as the absorption of albendazole is thought to be pH-dependent.  According to the product labeling, plasma concentrations of ABZSX are up to 5-fold higher on average when albendazole is administered with a fatty meal (fat content approximately 40 g) compared to administration in the fasted state.', 'grapefruit juice', 'Moderate', 'To ensure maximal oral absorption, albendazole should be taken with food.  Grapefruit juice may also enhance the oral bioavailability of albendazole.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4087, 12234, 'Albendazole', 'Food enhances the oral bioavailability of albendazole, which is rapidly converted by hepatocytes and intestinal mucosal cells into the active metabolite, albendazole sulfoxide (ABZSX), following absorption.  The proposed mechanism is stimulation of gastric acid secretion, as the absorption of albendazole is thought to be pH-dependent.  According to the product labeling, plasma concentrations of ABZSX are up to 5-fold higher on average when albendazole is administered with a fatty meal (fat content approximately 40 g) compared to administration in the fasted state.', 'grapefruit juice', 'Moderate', 'To ensure maximal oral absorption, albendazole should be taken with food.  Grapefruit juice may also enhance the oral bioavailability of albendazole.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4088, 12236, 'Albendazole', 'Food enhances the oral bioavailability of albendazole, which is rapidly converted by hepatocytes and intestinal mucosal cells into the active metabolite, albendazole sulfoxide (ABZSX), following absorption.  The proposed mechanism is stimulation of gastric acid secretion, as the absorption of albendazole is thought to be pH-dependent.  According to the product labeling, plasma concentrations of ABZSX are up to 5-fold higher on average when albendazole is administered with a fatty meal (fat content approximately 40 g) compared to administration in the fasted state.', 'grapefruit juice', 'Moderate', 'To ensure maximal oral absorption, albendazole should be taken with food.  Grapefruit juice may also enhance the oral bioavailability of albendazole.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4089, 13623, 'Albendazole', 'Food enhances the oral bioavailability of albendazole, which is rapidly converted by hepatocytes and intestinal mucosal cells into the active metabolite, albendazole sulfoxide (ABZSX), following absorption.  The proposed mechanism is stimulation of gastric acid secretion, as the absorption of albendazole is thought to be pH-dependent.  According to the product labeling, plasma concentrations of ABZSX are up to 5-fold higher on average when albendazole is administered with a fatty meal (fat content approximately 40 g) compared to administration in the fasted state.', 'grapefruit juice', 'Moderate', 'To ensure maximal oral absorption, albendazole should be taken with food.  Grapefruit juice may also enhance the oral bioavailability of albendazole.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4090, 13624, 'Albendazole', 'Food enhances the oral bioavailability of albendazole, which is rapidly converted by hepatocytes and intestinal mucosal cells into the active metabolite, albendazole sulfoxide (ABZSX), following absorption.  The proposed mechanism is stimulation of gastric acid secretion, as the absorption of albendazole is thought to be pH-dependent.  According to the product labeling, plasma concentrations of ABZSX are up to 5-fold higher on average when albendazole is administered with a fatty meal (fat content approximately 40 g) compared to administration in the fasted state.', 'grapefruit juice', 'Moderate', 'To ensure maximal oral absorption, albendazole should be taken with food.  Grapefruit juice may also enhance the oral bioavailability of albendazole.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4091, 13872, 'Albendazole', 'Food enhances the oral bioavailability of albendazole, which is rapidly converted by hepatocytes and intestinal mucosal cells into the active metabolite, albendazole sulfoxide (ABZSX), following absorption.  The proposed mechanism is stimulation of gastric acid secretion, as the absorption of albendazole is thought to be pH-dependent.  According to the product labeling, plasma concentrations of ABZSX are up to 5-fold higher on average when albendazole is administered with a fatty meal (fat content approximately 40 g) compared to administration in the fasted state.', 'grapefruit juice', 'Moderate', 'To ensure maximal oral absorption, albendazole should be taken with food.  Grapefruit juice may also enhance the oral bioavailability of albendazole.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4092, 15064, 'Albendazole', 'Food enhances the oral bioavailability of albendazole, which is rapidly converted by hepatocytes and intestinal mucosal cells into the active metabolite, albendazole sulfoxide (ABZSX), following absorption.  The proposed mechanism is stimulation of gastric acid secretion, as the absorption of albendazole is thought to be pH-dependent.  According to the product labeling, plasma concentrations of ABZSX are up to 5-fold higher on average when albendazole is administered with a fatty meal (fat content approximately 40 g) compared to administration in the fasted state.', 'grapefruit juice', 'Moderate', 'To ensure maximal oral absorption, albendazole should be taken with food.  Grapefruit juice may also enhance the oral bioavailability of albendazole.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4093, 2938, 'Chlordiazepoxide', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4094, 0, 'Albiglutide', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4095, 306, 'Chloroquine', 'Theoretically, grapefruit and grapefruit juice may increase the plasma concentrations of hydroxychloroquine or chloroquine and the risk of toxicities such as QT interval prolongation and ventricular arrhythmias.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall induced by certain compounds present in grapefruit.', 'grapefruit juice', 'Moderate', 'Although clinical data are lacking, it may be advisable to avoid the consumption of grapefruit, grapefruit juice, and any supplement containing grapefruit extract during hydroxychloroquine or chloroquine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4096, 2506, 'Chloroquine', 'Theoretically, grapefruit and grapefruit juice may increase the plasma concentrations of hydroxychloroquine or chloroquine and the risk of toxicities such as QT interval prolongation and ventricular arrhythmias.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall induced by certain compounds present in grapefruit.', 'grapefruit juice', 'Moderate', 'Although clinical data are lacking, it may be advisable to avoid the consumption of grapefruit, grapefruit juice, and any supplement containing grapefruit extract during hydroxychloroquine or chloroquine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4097, 16253, 'Chloroquine', 'Theoretically, grapefruit and grapefruit juice may increase the plasma concentrations of hydroxychloroquine or chloroquine and the risk of toxicities such as QT interval prolongation and ventricular arrhythmias.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall induced by certain compounds present in grapefruit.', 'grapefruit juice', 'Moderate', 'Although clinical data are lacking, it may be advisable to avoid the consumption of grapefruit, grapefruit juice, and any supplement containing grapefruit extract during hydroxychloroquine or chloroquine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4098, 16254, 'Chloroquine', 'Theoretically, grapefruit and grapefruit juice may increase the plasma concentrations of hydroxychloroquine or chloroquine and the risk of toxicities such as QT interval prolongation and ventricular arrhythmias.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall induced by certain compounds present in grapefruit.', 'grapefruit juice', 'Moderate', 'Although clinical data are lacking, it may be advisable to avoid the consumption of grapefruit, grapefruit juice, and any supplement containing grapefruit extract during hydroxychloroquine or chloroquine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4099, 22238, 'Chloroquine', 'Theoretically, grapefruit and grapefruit juice may increase the plasma concentrations of hydroxychloroquine or chloroquine and the risk of toxicities such as QT interval prolongation and ventricular arrhythmias.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall induced by certain compounds present in grapefruit.', 'grapefruit juice', 'Moderate', 'Although clinical data are lacking, it may be advisable to avoid the consumption of grapefruit, grapefruit juice, and any supplement containing grapefruit extract during hydroxychloroquine or chloroquine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4100, 257, 'Chlorothiazide', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4101, 1056, 'Chlorothiazide', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4102, 1059, 'Chlorothiazide', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4103, 1637, 'Chlorothiazide', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4104, 1641, 'Chlorothiazide', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4105, 1972, 'Chlorothiazide', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4106, 5459, 'Chlorothiazide', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4107, 7439, 'Chlorothiazide', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4108, 10204, 'Chlorothiazide', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4109, 13634, 'Chlorothiazide', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4110, 15743, 'Chlorothiazide', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4111, 15747, 'Chlorothiazide', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4112, 15753, 'Chlorothiazide', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4113, 15754, 'Chlorothiazide', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4114, 2707, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4115, 2710, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4116, 6465, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4117, 16329, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4118, 16330, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4119, 16331, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4120, 16332, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4121, 16451, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4122, 16453, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4123, 16455, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4124, 16581, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4125, 16583, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4126, 20796, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4127, 23018, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4128, 25010, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4129, 25011, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4130, 26692, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4131, 26693, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4132, 26816, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4133, 26817, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4134, 27487, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4135, 27488, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4136, 27489, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4137, 27952, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4138, 31976, 'Cilostazol', 'Grapefruit juice may increase the plasma concentrations of cilostazol.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The extent and clinical significance are unknown.  Moreover, pharmacokinetic alterations associated with interactions involving grapefruit juice are often subject to a high degree of interpatient variability.', 'grapefruit juice', 'Moderate', 'Until more information is available, the manufacturer recommends avoiding consumption of grapefruit juice during cilostazol therapy.  Orange juice is not expected to interact with cilostazol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4139, 7108, 'Chlorpromazine', 'Concurrent use of ethanol and phenothiazines may result in additive CNS depression and psychomotor impairment.  Also, ethanol may precipitate dystonic reactions in patients who are taking phenothiazines.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during phenothiazine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4140, 7109, 'Chlorpromazine', 'Concurrent use of ethanol and phenothiazines may result in additive CNS depression and psychomotor impairment.  Also, ethanol may precipitate dystonic reactions in patients who are taking phenothiazines.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during phenothiazine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4141, 7110, 'Chlorpromazine', 'Concurrent use of ethanol and phenothiazines may result in additive CNS depression and psychomotor impairment.  Also, ethanol may precipitate dystonic reactions in patients who are taking phenothiazines.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during phenothiazine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4142, 8736, 'Chlorpromazine', 'Concurrent use of ethanol and phenothiazines may result in additive CNS depression and psychomotor impairment.  Also, ethanol may precipitate dystonic reactions in patients who are taking phenothiazines.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during phenothiazine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4143, 23449, 'Chlorpromazine', 'Concurrent use of ethanol and phenothiazines may result in additive CNS depression and psychomotor impairment.  Also, ethanol may precipitate dystonic reactions in patients who are taking phenothiazines.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during phenothiazine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4144, 23451, 'Chlorpromazine', 'Concurrent use of ethanol and phenothiazines may result in additive CNS depression and psychomotor impairment.  Also, ethanol may precipitate dystonic reactions in patients who are taking phenothiazines.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during phenothiazine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4145, 25339, 'Chlorpromazine', 'Concurrent use of ethanol and phenothiazines may result in additive CNS depression and psychomotor impairment.  Also, ethanol may precipitate dystonic reactions in patients who are taking phenothiazines.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during phenothiazine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4146, 25340, 'Chlorpromazine', 'Concurrent use of ethanol and phenothiazines may result in additive CNS depression and psychomotor impairment.  Also, ethanol may precipitate dystonic reactions in patients who are taking phenothiazines.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during phenothiazine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4147, 16649, 'Chlorthalidone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4148, 274, 'Cinacalcet', 'Food enhances the oral absorption and bioavailability of cinacalcet.  According to the product labeling for cinacalcet, administration with a high-fat meal increased the peak plasma concentration (Cmax) and area under the concentration-time curve (AUC) of cinacalcet by 82% and 68%, respectively, compared to administration in the fasting state.  The Cmax and AUC were increased 65% and 50%, respectively, when cinacalcet was administered with a low-fat meal compared to fasting.', 'high-fat foods', 'Moderate', 'To ensure maximal oral absorption, cinacalcet should be administered with or immediately after a meal.  The tablets should be taken whole and not divided or crushed.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4149, 2595, 'Cinacalcet', 'Food enhances the oral absorption and bioavailability of cinacalcet.  According to the product labeling for cinacalcet, administration with a high-fat meal increased the peak plasma concentration (Cmax) and area under the concentration-time curve (AUC) of cinacalcet by 82% and 68%, respectively, compared to administration in the fasting state.  The Cmax and AUC were increased 65% and 50%, respectively, when cinacalcet was administered with a low-fat meal compared to fasting.', 'high-fat foods', 'Moderate', 'To ensure maximal oral absorption, cinacalcet should be administered with or immediately after a meal.  The tablets should be taken whole and not divided or crushed.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4150, 8182, 'Cinacalcet', 'Food enhances the oral absorption and bioavailability of cinacalcet.  According to the product labeling for cinacalcet, administration with a high-fat meal increased the peak plasma concentration (Cmax) and area under the concentration-time curve (AUC) of cinacalcet by 82% and 68%, respectively, compared to administration in the fasting state.  The Cmax and AUC were increased 65% and 50%, respectively, when cinacalcet was administered with a low-fat meal compared to fasting.', 'high-fat foods', 'Moderate', 'To ensure maximal oral absorption, cinacalcet should be administered with or immediately after a meal.  The tablets should be taken whole and not divided or crushed.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4151, 8183, 'Cinacalcet', 'Food enhances the oral absorption and bioavailability of cinacalcet.  According to the product labeling for cinacalcet, administration with a high-fat meal increased the peak plasma concentration (Cmax) and area under the concentration-time curve (AUC) of cinacalcet by 82% and 68%, respectively, compared to administration in the fasting state.  The Cmax and AUC were increased 65% and 50%, respectively, when cinacalcet was administered with a low-fat meal compared to fasting.', 'high-fat foods', 'Moderate', 'To ensure maximal oral absorption, cinacalcet should be administered with or immediately after a meal.  The tablets should be taken whole and not divided or crushed.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4152, 16337, 'Cinacalcet', 'Food enhances the oral absorption and bioavailability of cinacalcet.  According to the product labeling for cinacalcet, administration with a high-fat meal increased the peak plasma concentration (Cmax) and area under the concentration-time curve (AUC) of cinacalcet by 82% and 68%, respectively, compared to administration in the fasting state.  The Cmax and AUC were increased 65% and 50%, respectively, when cinacalcet was administered with a low-fat meal compared to fasting.', 'high-fat foods', 'Moderate', 'To ensure maximal oral absorption, cinacalcet should be administered with or immediately after a meal.  The tablets should be taken whole and not divided or crushed.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4153, 24549, 'Cinacalcet', 'Food enhances the oral absorption and bioavailability of cinacalcet.  According to the product labeling for cinacalcet, administration with a high-fat meal increased the peak plasma concentration (Cmax) and area under the concentration-time curve (AUC) of cinacalcet by 82% and 68%, respectively, compared to administration in the fasting state.  The Cmax and AUC were increased 65% and 50%, respectively, when cinacalcet was administered with a low-fat meal compared to fasting.', 'high-fat foods', 'Moderate', 'To ensure maximal oral absorption, cinacalcet should be administered with or immediately after a meal.  The tablets should be taken whole and not divided or crushed.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4154, 24550, 'Cinacalcet', 'Food enhances the oral absorption and bioavailability of cinacalcet.  According to the product labeling for cinacalcet, administration with a high-fat meal increased the peak plasma concentration (Cmax) and area under the concentration-time curve (AUC) of cinacalcet by 82% and 68%, respectively, compared to administration in the fasting state.  The Cmax and AUC were increased 65% and 50%, respectively, when cinacalcet was administered with a low-fat meal compared to fasting.', 'high-fat foods', 'Moderate', 'To ensure maximal oral absorption, cinacalcet should be administered with or immediately after a meal.  The tablets should be taken whole and not divided or crushed.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4155, 23011, 'Cisapride', 'Coadministration with grapefruit juice may increase the plasma concentrations of cisapride.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Major', 'Patients receiving cisapride therapy should avoid the consumption of grapefruits and grapefruit juice.  Because a significant interaction may occur with red wine in the occasional patient, red wine should preferably be avoided also during cisapride therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4156, 3361, 'Chlorzoxazone', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents such as chlorzoxazone.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.The proposed mechanism is inhibition of CYP450 2E1 metabolism.', 'alcohol', 'Moderate', 'Patients receiving chlorzoxazone should be advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how chlorzoxazone affects them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.  Watercress should be avoided if an interaction is suspected; e.g., excess sedation, nausea, or headache occurs.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4157, 24473, 'Chlorpropamide', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.  Episodes of hypoglycemia may last for 8 to 12 hours after ethanol ingestion.  By contrast, chronic alcohol abuse can cause impaired glucose tolerance and hyperglycemia.  Moderate alcohol consumption generally does not affect blood glucose levels in patients with well controlled diabetes.  A disulfiram-like reaction (e.g., flushing, headache, and nausea) to alcohol has been reported frequently with the use of chlorpropamide and very rarely with other sulfonylureas.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4158, 393, 'Chlorpheniramine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4159, 394, 'Chlorpheniramine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4160, 395, 'Chlorpheniramine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4161, 715, 'Chlorpheniramine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4162, 2500, 'Chlorpheniramine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4163, 14098, 'Chlorpheniramine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4164, 16251, 'Chlorpheniramine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4165, 16255, 'Chlorpheniramine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4166, 24953, 'Chlorpheniramine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4167, 24954, 'Chlorpheniramine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4168, 24955, 'Chlorpheniramine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4169, 32391, 'Chlorpheniramine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4170, 2590, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4171, 2621, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4172, 2622, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4173, 2624, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4174, 2626, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4175, 2627, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4176, 2628, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4177, 2630, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4178, 2631, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4179, 2632, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4180, 2633, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4181, 2638, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4182, 2639, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4183, 2640, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4184, 2642, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4185, 2643, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4186, 2644, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4187, 2647, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4188, 2649, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4189, 2650, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4190, 2651, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4191, 2652, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4192, 2653, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4193, 2654, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4194, 2657, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4195, 4081, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4196, 8164, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4197, 10377, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4198, 10378, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4199, 10379, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4200, 11908, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4201, 13099, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4202, 14349, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4203, 14876, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4204, 14877, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4205, 15492, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4206, 16363, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4207, 16367, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4208, 16373, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4209, 16376, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4210, 16379, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4211, 16383, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4212, 16384, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4213, 16388, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4214, 16389, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4215, 16391, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4216, 16398, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4217, 16399, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4218, 16402, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4219, 18192, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4220, 18194, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4221, 20298, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4222, 20299, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4223, 20300, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4224, 20427, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4225, 21255, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4226, 21429, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4227, 22588, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4228, 22740, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4229, 25055, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4230, 25555, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4231, 25682, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4232, 25684, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4233, 26237, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4234, 28683, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4235, 32068, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.', 'dairy products', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4236, 2590, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4237, 2621, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4238, 2622, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4239, 2624, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4240, 2626, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4241, 2627, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4242, 2628, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4243, 2630, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4244, 2631, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4245, 2632, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4246, 2633, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4247, 2638, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4248, 2639, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4249, 2640, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4250, 2642, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4251, 2643, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4252, 2644, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4253, 2647, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4254, 2649, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4255, 2650, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4256, 2651, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4257, 2652, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4258, 2653, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4259, 2654, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4260, 2657, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4261, 4081, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4262, 8164, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4263, 10377, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4264, 10378, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4265, 10379, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4266, 11908, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4267, 13099, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4268, 14349, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4269, 14876, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4270, 14877, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4271, 15492, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4272, 16363, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4273, 16367, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4274, 16373, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4275, 16376, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4276, 16379, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4277, 16383, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4278, 16384, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4279, 16388, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4280, 16389, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4281, 16391, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4282, 16398, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4283, 16399, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4284, 16402, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4285, 18192, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4286, 18194, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4287, 20298, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4288, 20299, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4289, 20300, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4290, 20427, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4291, 21255, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4292, 21429, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4293, 22588, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4294, 22740, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4295, 25055, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4296, 25555, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4297, 25682, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4298, 25684, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4299, 26237, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4300, 28683, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4301, 32068, 'Ciprofloxacin', 'Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.', 'orange juice', 'Moderate', 'Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4302, 13650, 'Alectinib', 'Food significantly enhances the oral bioavailability of alectinib and its major active metabolite, M4.  According to the manufacturer, a high-fat, high-calorie meal increased the combined systemic exposure (AUC) of alectinib and M4 by 3.1-fold following oral administration of a single 600 mg dose of alectinib.', 'high-fat foods', 'Moderate', 'To ensure maximal oral absorption, alectinib should be administered with food.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4303, 2416, 'Citalopram', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4304, 2612, 'Citalopram', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4305, 2614, 'Citalopram', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4306, 2615, 'Citalopram', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4307, 2669, 'Citalopram', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4308, 2671, 'Citalopram', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4309, 3431, 'Citalopram', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4310, 3432, 'Citalopram', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4311, 11143, 'Citalopram', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4312, 13055, 'Citalopram', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4313, 16416, 'Citalopram', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4314, 16419, 'Citalopram', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4315, 16420, 'Citalopram', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4316, 17272, 'Citalopram', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4317, 21672, 'Citalopram', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4318, 25493, 'Citalopram', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4319, 25638, 'Citalopram', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4320, 27870, 'Citalopram', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4321, 5425, 'Cimetidine', 'Concurrent use of cimetidine and ethanol may result in increased ethanol concentrations.  The mechanism appears to be due to inhibition of gastric alcohol dehydrogenase by cimetidine, leading to increased bioavailability of the alcohol and inhibition of hepatic metabolism of alcohol.', 'alcohol', 'Minor', 'The clinical significance of this interaction is limited.  More importantly, patients requiring cimetidine for gastrointestinal disease should be counseled to avoid alcohol to prevent worsening of their disease.  The other H-2 receptor antagonists appear to have minimal effects on the concentrations of alcohol.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4322, 2696, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4323, 2697, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4324, 2700, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4325, 6787, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4326, 6949, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4327, 6951, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4328, 6953, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4329, 6954, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4330, 6959, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4331, 6960, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4332, 6962, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4333, 13838, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4334, 14977, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4335, 15794, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4336, 16438, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4337, 16442, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4338, 16443, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4339, 20733, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4340, 20799, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4341, 20800, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4342, 21248, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4343, 21443, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4344, 21444, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4345, 21449, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4346, 21612, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4347, 21613, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4348, 30684, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4349, 30685, 'Clarithromycin', 'Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.', 'grapefruit juice', 'Minor', 'Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4350, 11206, 'Clemastine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4351, 11208, 'Clemastine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4352, 20516, 'Clemastine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4353, 27937, 'Clemastine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4354, 0, 'Clofedanol', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4355, 0, 'Clobazam', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4356, 0, 'Clofarabine', 'The liver is a known target organ for clofarabine toxicity, and concomitant use of other potentially hepatotoxic agents may increase the risk of liver injury.', 'alcohol', 'Moderate', 'Concomitant use of clofarabine with other potentially hepatotoxic agents should be avoided whenever possible (e.g., acetaminophen; alcohol; androgens and anabolic steroids; antituberculous agents; azole antifungal agents; ACE inhibitors; disulfiram; endothelin receptor antagonists; interferons; ketolide and macrolide antibiotics; kinase inhibitors; minocycline; nonsteroidal anti-inflammatory agents; nucleoside reverse transcriptase inhibitors; proteasome inhibitors; retinoids; sulfonamides; tamoxifen; thiazolidinediones; tolvaptan; vincristine; zileuton; anticonvulsants such as carbamazepine, hydantoins, felbamate, and valproic acid; lipid-lowering medications such as fenofibrate, lomitapide, mipomersen, niacin, and statins; herbals and nutritional supplements such as black cohosh, chaparral, comfrey, DHEA, kava, pennyroyal oil, and red yeast rice).  Hepatic function should be monitored during clofarabine administration, and therapy discontinued if grade 3 to 4 liver enzyme or bilirubin elevations occur.  Patients should be advised to seek medical attention if they experience potential signs and symptoms of hepatotoxicity such as fever, rash, itching, anorexia, nausea, vomiting, fatigue, malaise, right upper quadrant pain, dark urine, pale stools, and jaundice.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4357, 0, 'Clevidipine', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4358, 720, 'Clomipramine', 'The combination of ethanol and a tricyclic antidepressant may result in additive impairment of motor skills, especially driving skills.  Also, one study has suggested that clomipramine metabolism is significantly impaired for several weeks or more following discontinuation of chronic alcohol consumption.', 'alcohol', 'Moderate', 'Patients should be warned of this interaction and advised to limit their ethanol intake while taking tricyclic antidepressants.  Monitoring for TCA toxicity (CNS depression, excessive anticholinergic effects, hypotension, arrhythmias) is recommended during alcohol withdrawal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4359, 11056, 'Clomipramine', 'The combination of ethanol and a tricyclic antidepressant may result in additive impairment of motor skills, especially driving skills.  Also, one study has suggested that clomipramine metabolism is significantly impaired for several weeks or more following discontinuation of chronic alcohol consumption.', 'alcohol', 'Moderate', 'Patients should be warned of this interaction and advised to limit their ethanol intake while taking tricyclic antidepressants.  Monitoring for TCA toxicity (CNS depression, excessive anticholinergic effects, hypotension, arrhythmias) is recommended during alcohol withdrawal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4360, 11059, 'Clomipramine', 'The combination of ethanol and a tricyclic antidepressant may result in additive impairment of motor skills, especially driving skills.  Also, one study has suggested that clomipramine metabolism is significantly impaired for several weeks or more following discontinuation of chronic alcohol consumption.', 'alcohol', 'Moderate', 'Patients should be warned of this interaction and advised to limit their ethanol intake while taking tricyclic antidepressants.  Monitoring for TCA toxicity (CNS depression, excessive anticholinergic effects, hypotension, arrhythmias) is recommended during alcohol withdrawal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4361, 14090, 'Clomipramine', 'The combination of ethanol and a tricyclic antidepressant may result in additive impairment of motor skills, especially driving skills.  Also, one study has suggested that clomipramine metabolism is significantly impaired for several weeks or more following discontinuation of chronic alcohol consumption.', 'alcohol', 'Moderate', 'Patients should be warned of this interaction and advised to limit their ethanol intake while taking tricyclic antidepressants.  Monitoring for TCA toxicity (CNS depression, excessive anticholinergic effects, hypotension, arrhythmias) is recommended during alcohol withdrawal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4362, 14091, 'Clomipramine', 'The combination of ethanol and a tricyclic antidepressant may result in additive impairment of motor skills, especially driving skills.  Also, one study has suggested that clomipramine metabolism is significantly impaired for several weeks or more following discontinuation of chronic alcohol consumption.', 'alcohol', 'Moderate', 'Patients should be warned of this interaction and advised to limit their ethanol intake while taking tricyclic antidepressants.  Monitoring for TCA toxicity (CNS depression, excessive anticholinergic effects, hypotension, arrhythmias) is recommended during alcohol withdrawal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4363, 14103, 'Clomipramine', 'The combination of ethanol and a tricyclic antidepressant may result in additive impairment of motor skills, especially driving skills.  Also, one study has suggested that clomipramine metabolism is significantly impaired for several weeks or more following discontinuation of chronic alcohol consumption.', 'alcohol', 'Moderate', 'Patients should be warned of this interaction and advised to limit their ethanol intake while taking tricyclic antidepressants.  Monitoring for TCA toxicity (CNS depression, excessive anticholinergic effects, hypotension, arrhythmias) is recommended during alcohol withdrawal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4364, 14104, 'Clomipramine', 'The combination of ethanol and a tricyclic antidepressant may result in additive impairment of motor skills, especially driving skills.  Also, one study has suggested that clomipramine metabolism is significantly impaired for several weeks or more following discontinuation of chronic alcohol consumption.', 'alcohol', 'Moderate', 'Patients should be warned of this interaction and advised to limit their ethanol intake while taking tricyclic antidepressants.  Monitoring for TCA toxicity (CNS depression, excessive anticholinergic effects, hypotension, arrhythmias) is recommended during alcohol withdrawal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4365, 33730, 'Clomipramine', 'The combination of ethanol and a tricyclic antidepressant may result in additive impairment of motor skills, especially driving skills.  Also, one study has suggested that clomipramine metabolism is significantly impaired for several weeks or more following discontinuation of chronic alcohol consumption.', 'alcohol', 'Moderate', 'Patients should be warned of this interaction and advised to limit their ethanol intake while taking tricyclic antidepressants.  Monitoring for TCA toxicity (CNS depression, excessive anticholinergic effects, hypotension, arrhythmias) is recommended during alcohol withdrawal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4366, 720, 'Clomipramine', 'Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.', 'grapefruit juice', 'Moderate', 'Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4367, 11056, 'Clomipramine', 'Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.', 'grapefruit juice', 'Moderate', 'Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4368, 11059, 'Clomipramine', 'Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.', 'grapefruit juice', 'Moderate', 'Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4369, 14090, 'Clomipramine', 'Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.', 'grapefruit juice', 'Moderate', 'Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4370, 14091, 'Clomipramine', 'Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.', 'grapefruit juice', 'Moderate', 'Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4371, 14103, 'Clomipramine', 'Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.', 'grapefruit juice', 'Moderate', 'Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4372, 14104, 'Clomipramine', 'Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.', 'grapefruit juice', 'Moderate', 'Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4373, 33730, 'Clomipramine', 'Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.', 'grapefruit juice', 'Moderate', 'Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4374, 720, 'Clomipramine', 'Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.', 'cranberry juice', 'Moderate', 'Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4375, 11056, 'Clomipramine', 'Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.', 'cranberry juice', 'Moderate', 'Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4376, 11059, 'Clomipramine', 'Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.', 'cranberry juice', 'Moderate', 'Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4377, 14090, 'Clomipramine', 'Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.', 'cranberry juice', 'Moderate', 'Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4378, 14091, 'Clomipramine', 'Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.', 'cranberry juice', 'Moderate', 'Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4379, 14103, 'Clomipramine', 'Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.', 'cranberry juice', 'Moderate', 'Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4380, 14104, 'Clomipramine', 'Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.', 'cranberry juice', 'Moderate', 'Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4381, 33730, 'Clomipramine', 'Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.', 'cranberry juice', 'Moderate', 'Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4382, 15942, 'Clonidine', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4383, 15943, 'Clonidine', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', 'Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4384, 4293, 'Clidinium', 'Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous.  In addition, the potential for abuse may be increased with the combination.  The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system.', 'alcohol', 'Moderate', 'Alcohol should generally be avoided during therapy with anticholinergic agents.  Patients should be counseled to avoid activities requiring mental alertness until they know how these agents affect them.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4385, 7288, 'Clidinium', 'Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous.  In addition, the potential for abuse may be increased with the combination.  The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system.', 'alcohol', 'Moderate', 'Alcohol should generally be avoided during therapy with anticholinergic agents.  Patients should be counseled to avoid activities requiring mental alertness until they know how these agents affect them.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4386, 16508, 'Clidinium', 'Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous.  In addition, the potential for abuse may be increased with the combination.  The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system.', 'alcohol', 'Moderate', 'Alcohol should generally be avoided during therapy with anticholinergic agents.  Patients should be counseled to avoid activities requiring mental alertness until they know how these agents affect them.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4387, 16567, 'Clidinium', 'Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous.  In addition, the potential for abuse may be increased with the combination.  The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system.', 'alcohol', 'Moderate', 'Alcohol should generally be avoided during therapy with anticholinergic agents.  Patients should be counseled to avoid activities requiring mental alertness until they know how these agents affect them.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4388, 17604, 'Clidinium', 'Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous.  In addition, the potential for abuse may be increased with the combination.  The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system.', 'alcohol', 'Moderate', 'Alcohol should generally be avoided during therapy with anticholinergic agents.  Patients should be counseled to avoid activities requiring mental alertness until they know how these agents affect them.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4389, 623, 'Clonazepam', 'Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during benzodiazepine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4390, 624, 'Clonazepam', 'Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during benzodiazepine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4391, 833, 'Clonazepam', 'Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during benzodiazepine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4392, 836, 'Clonazepam', 'Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during benzodiazepine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4393, 2790, 'Clonazepam', 'Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during benzodiazepine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4394, 6978, 'Clonazepam', 'Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during benzodiazepine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4395, 9926, 'Clonazepam', 'Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during benzodiazepine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4396, 21459, 'Clonazepam', 'Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during benzodiazepine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4397, 21460, 'Clonazepam', 'Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during benzodiazepine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4398, 26216, 'Clonazepam', 'Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during benzodiazepine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4399, 26217, 'Clonazepam', 'Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during benzodiazepine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4400, 26266, 'Clonazepam', 'Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during benzodiazepine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4401, 26267, 'Clonazepam', 'Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during benzodiazepine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4402, 26951, 'Clonazepam', 'Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during benzodiazepine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4403, 26952, 'Clonazepam', 'Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.', 'alcohol', 'Moderate', 'Patients should be advised to avoid alcohol during benzodiazepine therapy.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4404, 24890, 'Clorazepic acid', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4405, 2822, 'Clozapine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4406, 2823, 'Clozapine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4407, 2824, 'Clozapine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4408, 2825, 'Clozapine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4409, 2826, 'Clozapine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4410, 2828, 'Clozapine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4411, 7201, 'Clozapine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4412, 21703, 'Clozapine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4413, 22439, 'Clozapine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4414, 25683, 'Clozapine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4415, 26611, 'Clozapine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4416, 26612, 'Clozapine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4417, 29811, 'Clozapine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4418, 24890, 'Alendronic acid', 'Food significantly decreases the bioavailability of alendronate, possibly to negligible levels.', 'food', 'Moderate', 'Alendronate should be administered with 6 to 8 ounces of plain water, at least 30 minutes before the first food, beverage, or medication of the day.  Patients should remain upright for at least 30 minutes following administration of alendronate.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4419, 1744, 'Codeine', 'Ethanol may potentiate the central nervous system (CNS) depressant effects of opioid analgesics.  Concomitant use may result in additive CNS depression and impairment of judgment, thinking, and psychomotor skills.  In more severe cases, hypotension, respiratory depression, profound sedation, coma, or even death may occur.', 'alcohol', 'Moderate', 'Concomitant use of opioid analgesics with ethanol should be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4420, 0, 'Cobimetinib', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme, such as cobimetinib.  However, the interaction seems to affect primarily those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability), presumably due to the fact that grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4.', 'grapefruit juice', 'Moderate', 'Patients who regularly consume grapefruit or grapefruit juice should be monitored for adverse effects and altered plasma concentrations of cobimetinib.  Grapefruit and grapefruit juice should be avoided if an interaction is suspected.  Orange juice is not expected to interact with these drugs.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4421, 0, 'Alfentanil', 'Ethanol may potentiate the central nervous system (CNS) depressant effects of opioid analgesics.  Concomitant use may result in additive CNS depression and impairment of judgment, thinking, and psychomotor skills.  In more severe cases, hypotension, respiratory depression, profound sedation, coma, or even death may occur.', 'alcohol', 'Moderate', 'Concomitant use of opioid analgesics with ethanol should be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4422, 2886, 'Colchicine', 'Coadministration with grapefruit juice may increase the serum concentrations of colchicine.  Clinical toxicity including myopathy, neuropathy, multiorgan failure, and pancytopenia may occur.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism and P-glycoprotein efflux in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Major', 'Patients treated with colchicine should be advised to avoid the consumption of grapefruit and grapefruit juice, and to contact their physician if they experience symptoms of colchicine toxicity such as abdominal pain, nausea, vomiting, diarrhea, fatigue, myalgia, asthenia, hyporeflexia, paresthesia, and numbness.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4423, 7714, 'Colchicine', 'Coadministration with grapefruit juice may increase the serum concentrations of colchicine.  Clinical toxicity including myopathy, neuropathy, multiorgan failure, and pancytopenia may occur.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism and P-glycoprotein efflux in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Major', 'Patients treated with colchicine should be advised to avoid the consumption of grapefruit and grapefruit juice, and to contact their physician if they experience symptoms of colchicine toxicity such as abdominal pain, nausea, vomiting, diarrhea, fatigue, myalgia, asthenia, hyporeflexia, paresthesia, and numbness.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4424, 7718, 'Colchicine', 'Coadministration with grapefruit juice may increase the serum concentrations of colchicine.  Clinical toxicity including myopathy, neuropathy, multiorgan failure, and pancytopenia may occur.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism and P-glycoprotein efflux in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Major', 'Patients treated with colchicine should be advised to avoid the consumption of grapefruit and grapefruit juice, and to contact their physician if they experience symptoms of colchicine toxicity such as abdominal pain, nausea, vomiting, diarrhea, fatigue, myalgia, asthenia, hyporeflexia, paresthesia, and numbness.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4425, 16617, 'Colchicine', 'Coadministration with grapefruit juice may increase the serum concentrations of colchicine.  Clinical toxicity including myopathy, neuropathy, multiorgan failure, and pancytopenia may occur.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism and P-glycoprotein efflux in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Major', 'Patients treated with colchicine should be advised to avoid the consumption of grapefruit and grapefruit juice, and to contact their physician if they experience symptoms of colchicine toxicity such as abdominal pain, nausea, vomiting, diarrhea, fatigue, myalgia, asthenia, hyporeflexia, paresthesia, and numbness.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4426, 16618, 'Colchicine', 'Coadministration with grapefruit juice may increase the serum concentrations of colchicine.  Clinical toxicity including myopathy, neuropathy, multiorgan failure, and pancytopenia may occur.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism and P-glycoprotein efflux in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Major', 'Patients treated with colchicine should be advised to avoid the consumption of grapefruit and grapefruit juice, and to contact their physician if they experience symptoms of colchicine toxicity such as abdominal pain, nausea, vomiting, diarrhea, fatigue, myalgia, asthenia, hyporeflexia, paresthesia, and numbness.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4427, 16651, 'Colchicine', 'Coadministration with grapefruit juice may increase the serum concentrations of colchicine.  Clinical toxicity including myopathy, neuropathy, multiorgan failure, and pancytopenia may occur.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism and P-glycoprotein efflux in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Major', 'Patients treated with colchicine should be advised to avoid the consumption of grapefruit and grapefruit juice, and to contact their physician if they experience symptoms of colchicine toxicity such as abdominal pain, nausea, vomiting, diarrhea, fatigue, myalgia, asthenia, hyporeflexia, paresthesia, and numbness.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4428, 30612, 'Colchicine', 'Coadministration with grapefruit juice may increase the serum concentrations of colchicine.  Clinical toxicity including myopathy, neuropathy, multiorgan failure, and pancytopenia may occur.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism and P-glycoprotein efflux in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Major', 'Patients treated with colchicine should be advised to avoid the consumption of grapefruit and grapefruit juice, and to contact their physician if they experience symptoms of colchicine toxicity such as abdominal pain, nausea, vomiting, diarrhea, fatigue, myalgia, asthenia, hyporeflexia, paresthesia, and numbness.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4429, 13724, 'Alfuzosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', 'Patients who develop  a flushing reaction after ethanol ingestion (indicates a possible aldehyde dehydrogenase deficiency) should be advised to avoid ethanol or limit their intake.  All patients should be warned about the possibility of orthostatic hypotension with concurrent ethanol use.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4430, 15074, 'Alfuzosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', 'Patients who develop  a flushing reaction after ethanol ingestion (indicates a possible aldehyde dehydrogenase deficiency) should be advised to avoid ethanol or limit their intake.  All patients should be warned about the possibility of orthostatic hypotension with concurrent ethanol use.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4431, 25400, 'Alfuzosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', 'Patients who develop  a flushing reaction after ethanol ingestion (indicates a possible aldehyde dehydrogenase deficiency) should be advised to avoid ethanol or limit their intake.  All patients should be warned about the possibility of orthostatic hypotension with concurrent ethanol use.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4432, 29722, 'Alfuzosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', 'Patients who develop  a flushing reaction after ethanol ingestion (indicates a possible aldehyde dehydrogenase deficiency) should be advised to avoid ethanol or limit their intake.  All patients should be warned about the possibility of orthostatic hypotension with concurrent ethanol use.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4433, 29723, 'Alfuzosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', 'Patients who develop  a flushing reaction after ethanol ingestion (indicates a possible aldehyde dehydrogenase deficiency) should be advised to avoid ethanol or limit their intake.  All patients should be warned about the possibility of orthostatic hypotension with concurrent ethanol use.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4434, 13724, 'Alfuzosin', 'Administration of alfuzosin with food enhances oral bioavailability.  According to the manufacturer, extent of absorption is 50% higher when administered under fed conditions compared to fasting conditions.', 'food', 'Moderate', 'To ensure maximal oral absorption, alfuzosin should be administered with or immediately after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4435, 15074, 'Alfuzosin', 'Administration of alfuzosin with food enhances oral bioavailability.  According to the manufacturer, extent of absorption is 50% higher when administered under fed conditions compared to fasting conditions.', 'food', 'Moderate', 'To ensure maximal oral absorption, alfuzosin should be administered with or immediately after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4436, 25400, 'Alfuzosin', 'Administration of alfuzosin with food enhances oral bioavailability.  According to the manufacturer, extent of absorption is 50% higher when administered under fed conditions compared to fasting conditions.', 'food', 'Moderate', 'To ensure maximal oral absorption, alfuzosin should be administered with or immediately after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4437, 29722, 'Alfuzosin', 'Administration of alfuzosin with food enhances oral bioavailability.  According to the manufacturer, extent of absorption is 50% higher when administered under fed conditions compared to fasting conditions.', 'food', 'Moderate', 'To ensure maximal oral absorption, alfuzosin should be administered with or immediately after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4438, 29723, 'Alfuzosin', 'Administration of alfuzosin with food enhances oral bioavailability.  According to the manufacturer, extent of absorption is 50% higher when administered under fed conditions compared to fasting conditions.', 'food', 'Moderate', 'To ensure maximal oral absorption, alfuzosin should be administered with or immediately after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4439, 0, 'Conjugated estrogens', 'Coadministration with grapefruit juice may increase the bioavailability of oral estrogens.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall induced by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', 'It is not recommended to eat or drink foods containing grapefruit while taking any est', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4440, 29699, 'Crizotinib', 'Grapefruit juice may increase the plasma concentrations of crizotinib.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Major', 'Patients treated with crizotinib should avoid consumption of grapefruit, grapefruit juice, and any supplement containing grapefruit extract.  Crizotinib may be taken without regards to food.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4441, 29700, 'Crizotinib', 'Grapefruit juice may increase the plasma concentrations of crizotinib.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Major', 'Patients treated with crizotinib should avoid consumption of grapefruit, grapefruit juice, and any supplement containing grapefruit extract.  Crizotinib may be taken without regards to food.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4442, 0, 'Copanlisib', 'Grapefruit juice may increase the plasma concentrations of copanlisib.  The proposed mechanism is inhibition of CYP450 3A4-mediated metabolism of copanlisib by certain compounds present in grapefruit.', 'grapefruit juice', 'Moderate', 'Patients should avoid the consumption of grapefruit and grapefruit juice during treatment with copanlisib.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4443, 3243, 'Cyproheptadine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4444, 11631, 'Cyproheptadine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4445, 11632, 'Cyproheptadine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4446, 0, 'Cycloserine', 'Coadministration with alcohol may potentiate some of the central nervous system adverse effects of cycloserine and its prodrug, terizidone.  These effects may include dizziness, drowsiness, depression, anxiety, psychoses, memory impairment, confusion, and convulsions.', 'alcohol', 'Major', 'Caution is advised when cycloserine or terizidone is used with caffeine.  Consumption of certain beverages or stimulants with very high caffeine levels should be avoided as a precautionary measure.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4447, 7483, 'Cyclobenzaprine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4448, 7489, 'Cyclobenzaprine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4449, 7571, 'Cyclobenzaprine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4450, 8437, 'Cyclobenzaprine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4451, 8438, 'Cyclobenzaprine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4452, 16988, 'Cyclobenzaprine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4453, 16989, 'Cyclobenzaprine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4454, 23013, 'Cyclobenzaprine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4455, 23014, 'Cyclobenzaprine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4456, 25264, 'Cyclobenzaprine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4457, 31131, 'Cyclobenzaprine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4458, 33230, 'Cyclobenzaprine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4459, 33437, 'Cyclobenzaprine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', 'Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4460, 20833, 'Aliskiren', 'Coadministration with orange, apple, or grapefruit juice may significantly decrease the oral bioavailability and renin-inhibiting effect of aliskiren.  The exact mechanism of interaction is unknown, but may include inhibition of OATP2B1-mediated influx of aliskiren in the small intestine, formation of insoluble complexes between fruit juice constituents and aliskiren, and/or increased ionization of aliskiren due to reduced intestinal pH.', 'grapefruit juice', 'Moderate', 'To ensure steady systemic drug levels and therapeutic effects, patients should establish a routine pattern for administration of aliskiren with regard to meals.  Coadministration with orange, apple, or grapefruit juice should be avoided, especially if these juices are to be consumed on a regular basis or shortly before or after aliskiren dosing.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4461, 20833, 'Aliskiren', 'Coadministration with orange, apple, or grapefruit juice may significantly decrease the oral bioavailability and renin-inhibiting effect of aliskiren.  The exact mechanism of interaction is unknown, but may include inhibition of OATP2B1-mediated influx of aliskiren in the small intestine, formation of insoluble complexes between fruit juice constituents and aliskiren, and/or increased ionization of aliskiren due to reduced intestinal pH.', 'orange juice', 'Moderate', 'To ensure steady systemic drug levels and therapeutic effects, patients should establish a routine pattern for administration of aliskiren with regard to meals.  Coadministration with orange, apple, or grapefruit juice should be avoided, especially if these juices are to be consumed on a regular basis or shortly before or after aliskiren dosing.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4462, 0, 'Dabrafenib', 'Food may reduce as well as delay the absorption of dabrafenib.  In study subjects, administration of dabrafenib with a high-fat meal decreased peak plasma concentration (Cmax) and systemic exposure (AUC) by 51% and 31%, respectively, and delayed median Tmax by approximately 3.6 hours compared to administration in the fasted state.', 'high-fat foods', 'Moderate', 'Dabrafenib should be taken at least 1 hour before or 2 hours after a meal.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4463, 963, 'Cyclosporine', 'Administration with grapefruit juice (compared to water or orange juice) has been shown to increase blood concentrations of cyclosporine with a relatively high degree of interpatient variability.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', 'Patients receiving cyclosporine therapy should be advised to either refrain from or avoid fluctuations in the consumption of grapefruits and grapefruit juice.  Until more data are available, the consumption of red wine or purple grape juice should preferably be avoided or limited.  All oral formulations of cyclosporine should be administered on a consistent schedule with regard to time of day and relation to meals so as to avoid large fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4464, 3210, 'Cyclosporine', 'Administration with grapefruit juice (compared to water or orange juice) has been shown to increase blood concentrations of cyclosporine with a relatively high degree of interpatient variability.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', 'Patients receiving cyclosporine therapy should be advised to either refrain from or avoid fluctuations in the consumption of grapefruits and grapefruit juice.  Until more data are available, the consumption of red wine or purple grape juice should preferably be avoided or limited.  All oral formulations of cyclosporine should be administered on a consistent schedule with regard to time of day and relation to meals so as to avoid large fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4465, 14087, 'Cyclosporine', 'Administration with grapefruit juice (compared to water or orange juice) has been shown to increase blood concentrations of cyclosporine with a relatively high degree of interpatient variability.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', 'Patients receiving cyclosporine therapy should be advised to either refrain from or avoid fluctuations in the consumption of grapefruits and grapefruit juice.  Until more data are available, the consumption of red wine or purple grape juice should preferably be avoided or limited.  All oral formulations of cyclosporine should be administered on a consistent schedule with regard to time of day and relation to meals so as to avoid large fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4466, 14422, 'Cyclosporine', 'Administration with grapefruit juice (compared to water or orange juice) has been shown to increase blood concentrations of cyclosporine with a relatively high degree of interpatient variability.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', 'Patients receiving cyclosporine therapy should be advised to either refrain from or avoid fluctuations in the consumption of grapefruits and grapefruit juice.  Until more data are available, the consumption of red wine or purple grape juice should preferably be avoided or limited.  All oral formulations of cyclosporine should be administered on a consistent schedule with regard to time of day and relation to meals so as to avoid large fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4467, 25927, 'Cyclosporine', 'Administration with grapefruit juice (compared to water or orange juice) has been shown to increase blood concentrations of cyclosporine with a relatively high degree of interpatient variability.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', 'Patients receiving cyclosporine therapy should be advised to either refrain from or avoid fluctuations in the consumption of grapefruits and grapefruit juice.  Until more data are available, the consumption of red wine or purple grape juice should preferably be avoided or limited.  All oral formulations of cyclosporine should be administered on a consistent schedule with regard to time of day and relation to meals so as to avoid large fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4468, 26491, 'Cyclosporine', 'Administration with grapefruit juice (compared to water or orange juice) has been shown to increase blood concentrations of cyclosporine with a relatively high degree of interpatient variability.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', 'Patients receiving cyclosporine therapy should be advised to either refrain from or avoid fluctuations in the consumption of grapefruits and grapefruit juice.  Until more data are available, the consumption of red wine or purple grape juice should preferably be avoided or limited.  All oral formulations of cyclosporine should be administered on a consistent schedule with regard to time of day and relation to meals so as to avoid large fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4469, 26492, 'Cyclosporine', 'Administration with grapefruit juice (compared to water or orange juice) has been shown to increase blood concentrations of cyclosporine with a relatively high degree of interpatient variability.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', 'Patients receiving cyclosporine therapy should be advised to either refrain from or avoid fluctuations in the consumption of grapefruits and grapefruit juice.  Until more data are available, the consumption of red wine or purple grape juice should preferably be avoided or limited.  All oral formulations of cyclosporine should be administered on a consistent schedule with regard to time of day and relation to meals so as to avoid large fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4470, 26493, 'Cyclosporine', 'Administration with grapefruit juice (compared to water or orange juice) has been shown to increase blood concentrations of cyclosporine with a relatively high degree of interpatient variability.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', 'Patients receiving cyclosporine therapy should be advised to either refrain from or avoid fluctuations in the consumption of grapefruits and grapefruit juice.  Until more data are available, the consumption of red wine or purple grape juice should preferably be avoided or limited.  All oral formulations of cyclosporine should be administered on a consistent schedule with regard to time of day and relation to meals so as to avoid large fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4471, 26494, 'Cyclosporine', 'Administration with grapefruit juice (compared to water or orange juice) has been shown to increase blood concentrations of cyclosporine with a relatively high degree of interpatient variability.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', 'Patients receiving cyclosporine therapy should be advised to either refrain from or avoid fluctuations in the consumption of grapefruits and grapefruit juice.  Until more data are available, the consumption of red wine or purple grape juice should preferably be avoided or limited.  All oral formulations of cyclosporine should be administered on a consistent schedule with regard to time of day and relation to meals so as to avoid large fluctuations in plasma drug levels.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4472, 4962, 'Darunavir', 'Food enhances the absorption and oral bioavailability of darunavir administered in combination with low-dose ritonavir.  The mechanism is unknown.', 'food', 'Moderate', 'To ensure maximal oral absorption, darunavir coadministered with ritonavir should be taken with food.  The type of food is not important.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4473, 1599, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4474, 6775, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4475, 7745, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4476, 7974, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4477, 7975, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4478, 8311, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4479, 9025, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4480, 13384, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4481, 13629, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4482, 13630, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4483, 17105, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4484, 17106, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4485, 17652, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4486, 17653, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4487, 19328, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4488, 19361, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4489, 19362, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4490, 22877, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4491, 23654, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4492, 25693, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4493, 29861, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4494, 30601, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4495, 30602, 'Dapagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', 'Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4496, 4352, 'Darolutamide', 'Food enhances the oral absorption of darolutamide.  According to the prescribing information, bioavailability of darolutamide increased by 2.0 to 2.5-fold when administered with food.  A similar increase in exposure was observed for the active metabolite keto-darolutamide.', 'food', 'Moderate', 'Darolutamide should be administered with food.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4497, 14119, 'Darifenacin', 'The consumption of grapefruit juice may be associated with increased plasma concentrations of darifenacin.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', 'Concomitant use of Darifenacin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4498, 17115, 'Darifenacin', 'The consumption of grapefruit juice may be associated with increased plasma concentrations of darifenacin.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', 'Concomitant use of Darifenacin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4499, 17116, 'Darifenacin', 'The consumption of grapefruit juice may be associated with increased plasma concentrations of darifenacin.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', 'Concomitant use of Darifenacin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);
INSERT INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, management_text, mechanism_text, reference_text, source, created_at) VALUES (4500, 19401, 'Darifenacin', 'The consumption of grapefruit juice may be associated with increased plasma concentrations of darifenacin.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.', 'grapefruit juice', 'Minor', 'Concomitant use of Darifenacin with grapefruit or grapefruit juice should generally be avoided.', '', '', 'DDInter', 0);